{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:55:23Z","timestamp":1794275723864,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Few studies have reported the relationship between retinal artery occlusion (RAO) and plasma homocysteine (Hcy) levels. Our goal was to evaluate the association between the plasma Hcy level and the risk of RAO disease. Several databases were searched for all published studies that involved Hcy and RAO. Six studies evaluated hyperhomocysteinemia (hHcy) in retinal artery occlusion patients and controls; the incidence of hHcy in patients with RAO was higher than the control and the pooled odds ratio (OR) was 6.64 (95% confidence interval (CI): 3.42, 12.89). Subgroup analyses showed that the ORs were 4.77 (95% CI: 2.69, 8.46) in Western countries, 22.19 (95% CI: 2.46, 200.37) in Asian countries, 9.70 (95% CI: 4.43, 21.20) in the age matched group, 11.41 (95% CI: 3.32, 39.18) in the sex matched group, 9.70 (95% CI: 4.37, 21.53) in the healthy control group, and 6.82 (95% CI: 4.19, 11.10) in the sample size &gt;30. The mean plasma Hcy level from 5 case-control studies was higher than controls, and the weighted mean difference (WMD) was 6.54 (95% CI: 2.79, 10.29). Retinal artery occlusion is associated with elevated plasma Hcy levels. Our study results suggest that hHcy is probably an independent risk factor for RAO.<\/jats:p>","DOI":"10.1038\/s41598-017-16065-2","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:03:15Z","timestamp":1510315395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Homocysteine in retinal artery occlusive disease: A meta-analysis of cohort studies"],"prefix":"10.1038","volume":"7","author":[{"given":"Xuetao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-4388","authenticated-orcid":false,"given":"Yi-Qun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"16065_CR1","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1097\/OPX.0000000000000707","volume":"92","author":"A Consigli","year":"2015","unstructured":"Consigli, A. et al. Diagnostic dilemma in sequential branch retinal vein and artery occlusion. Optom Vis Sci \n                           92, e404\u2013408 (2015).","journal-title":"Optom Vis Sci"},{"key":"16065_CR2","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ophtha.2015.05.018","volume":"122","author":"KD Beck","year":"2015","unstructured":"Beck, K. D. & Hernandez, L. Central retinal artery occlusion in a 21-year-old boxer. Ophthalmology \n                           122, 1568 (2015).","journal-title":"Ophthalmology"},{"key":"16065_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ophtha.2016.02.002","volume":"123","author":"M Fuest","year":"2016","unstructured":"Fuest, M., Djalali-Talab, Y. & Walter, P. Central retinal artery occlusion in a teenager. Ophthalmology \n                           123, 907 (2016).","journal-title":"Ophthalmology"},{"key":"16065_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-28","volume":"14","author":"A Fiess","year":"2014","unstructured":"Fiess, A. et al. Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy? BMC Ophthalmol \n                           14, 28 (2014).","journal-title":"BMC Ophthalmol"},{"key":"16065_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag, M., Youn, T., Schindler, J., Kirshner, H. & Greer, D. Intravenous fibrinolytic therapy in central retinal artery occlusion: A patient-level Meta-analysis. JAMA Neurol \n                           72, 1148\u20131154 (2015).","journal-title":"JAMA Neurol"},{"key":"16065_CR6","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1167\/iovs.14-16203","volume":"56","author":"C Dysli","year":"2015","unstructured":"Dysli, C., Wolf, S. & Zinkernagel, M. S. Fluorescence lifetime imaging in retinal artery occlusion. Invest Ophthalmol Vis Sci \n                           56, 3329\u20133336 (2015).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"16065_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","volume":"41","author":"SS Hayreh","year":"2014","unstructured":"Hayreh, S. S. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res \n                           41, 1\u201325 (2014).","journal-title":"Prog Retin Eye Res"},{"key":"16065_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11940-012-0202-9","volume":"15","author":"S Cugati","year":"2013","unstructured":"Cugati, S., Varma, D. D., Chen, C. S. & Lee, A. W. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol \n                           15, 63\u201377 (2013).","journal-title":"Curr Treat Options Neurol"},{"key":"16065_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0126-8","volume":"15","author":"CW Lu","year":"2015","unstructured":"Lu, C. W. et al. Central retinal artery occlusion associated with persistent truncus arteriosus and single atrium: a case report. BMC Ophthalmol \n                           15, 137 (2015).","journal-title":"BMC Ophthalmol"},{"key":"16065_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2147\/OPTH.S82796","volume":"9","author":"JR Mason","year":"2015","unstructured":"Mason, J. R. et al. Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion. Clin Ophthalmol \n                           9, 995\u20131000 (2015).","journal-title":"Clin Ophthalmol"},{"key":"16065_CR11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/1076029613513320","volume":"21","author":"J Chapin","year":"2015","unstructured":"Chapin, J., Carlson, K., Christos, P. J. & DeSancho, M. T. Risk factors and treatment strategies in patients with retinal vascular occlusions. Clin Appl Thromb Hemost \n                           21, 672\u2013677 (2015).","journal-title":"Clin Appl Thromb Hemost"},{"key":"16065_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/IIO.0000000000000087","volume":"55","author":"AL Gilbert","year":"2015","unstructured":"Gilbert, A. L., Choi, C. & Lessell, S. Acute management of central retinal artery occlusion. Int Ophthalmol Clin \n                           55, 157\u2013166 (2015).","journal-title":"Int Ophthalmol Clin"},{"key":"16065_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.survophthal.2014.12.003","volume":"60","author":"M Lawlor","year":"2015","unstructured":"Lawlor, M., Perry, R., Hunt, B. J. & Plant, G. T. Strokes and vision: The management of ischemic arterial disease affecting the retina and occipital lobe. Surv Ophthalmol \n                           60, 296\u2013309 (2015).","journal-title":"Surv Ophthalmol"},{"key":"16065_CR14","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajo.2014.01.033","volume":"157","author":"J Lee","year":"2014","unstructured":"Lee, J. et al. Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study. AM J Ophthalmol \n                           157, 1231\u20131238 (2014).","journal-title":"AM J Ophthalmol"},{"key":"16065_CR15","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.ophtha.2015.07.018","volume":"122","author":"SJ Park","year":"2015","unstructured":"Park, S. J. et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology \n                           122, 2336\u20132343 (2015).","journal-title":"Ophthalmology"},{"key":"16065_CR16","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2015.05.044","volume":"122","author":"J Callizo","year":"2015","unstructured":"Callizo, J. et al. Cardiovascular risk factors in central retinal artery occlusion: Results of a prospective and standardized medical examination. Ophthalmology \n                           122, 1881\u20131888 (2015).","journal-title":"Ophthalmology"},{"key":"16065_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00417-014-2804-2","volume":"253","author":"C Leisser","year":"2015","unstructured":"Leisser, C. et al. Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graefes Arch Clin Exp Ophthalmol \n                           253, 1227\u20131230 (2015).","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"16065_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/STROKEAHA.115.010828","volume":"47","author":"TH Rim","year":"2016","unstructured":"Rim, T. H. et al. Retinal artery occlusion and the risk of stroke development: Twelve-year nationwide cohort Study. Stroke \n                           47, 376\u2013382 (2016).","journal-title":"Stroke"},{"key":"16065_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1160\/TH11-12-0899","volume":"108","author":"A Dragani","year":"2012","unstructured":"Dragani, A. et al. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C-T polymorphism. Thromb Haemost \n                           108, 533\u2013542 (2012).","journal-title":"Thromb Haemost"},{"key":"16065_CR20","first-page":"887","volume":"66","author":"M Kovalska","year":"2015","unstructured":"Kovalska, M. et al. Combination of hyperhomocysteinemia and ischemic tolerance in experimental model of global ischemia in rats. J Physiol Pharmacol \n                           66, 887\u2013897 (2015).","journal-title":"J Physiol Pharmacol"},{"key":"16065_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep05663","volume":"4","author":"T Okura","year":"2014","unstructured":"Okura, T. et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep \n                           4, 5663 (2014).","journal-title":"Sci Rep"},{"key":"16065_CR22","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3390\/nu8010034","volume":"8","author":"D Rajdl","year":"2016","unstructured":"Rajdl, D. et al. Effect of folic acid, betaine, vitamin B(6), and vitamin B12 on homocysteine and dimethylglycine levels in middle-aged men drinking white wine. Nutrients \n                           8, e34 (2016).","journal-title":"Nutrients"},{"key":"16065_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1160\/TH09-11-0772","volume":"104","author":"M Sartori","year":"2010","unstructured":"Sartori, M. et al. Thrombophilic risk factors and peripheral arterial disease severity. Thromb Haemost \n                           104, 71\u201377 (2010).","journal-title":"Thromb Haemost"},{"key":"16065_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/112067210201200608","volume":"12","author":"EA Abu","year":"2002","unstructured":"Abu, E. A., Abdel, G. A., Al-Amro, S. A. & Al-Attas, O. S. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol \n                           12, 495\u2013500 (2002).","journal-title":"Eur J Ophthalmol"},{"key":"16065_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10384-005-0190-3","volume":"49","author":"LO Atchaneeyasakul","year":"2005","unstructured":"Atchaneeyasakul, L. O., Trinavarat, A., Bumrungsuk, P. & Wongsawad, W. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients. Jpn J Ophthalmol \n                           49, 211\u2013215 (2005).","journal-title":"Jpn J Ophthalmol"},{"key":"16065_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/bjo.84.2.154","volume":"84","author":"M Cahill","year":"2000","unstructured":"Cahill, M. et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol \n                           84, 154\u2013157 (2000).","journal-title":"Br J Ophthalmol"},{"key":"16065_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ajo.2006.03.039","volume":"142","author":"B Chua","year":"2006","unstructured":"Chua, B., Kifley, A., Wong, T. Y. & Mitchell, P. Homocysteine and retinal emboli: the Blue Mountains Eye Study. Am J Ophthalmol \n                           142, 322\u2013324 (2006).","journal-title":"Am J Ophthalmol"},{"issue":"Pt 4","key":"16065_CR28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/eye.2000.148","volume":"14","author":"SC Martin","year":"2000","unstructured":"Martin, S. C. et al. Plasma total homocysteine and retinal vascular disease. Eye (Lond) \n                           14(Pt 4), 590\u2013593 (2000).","journal-title":"Eye (Lond)"},{"key":"16065_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5144\/0256-4947.2004.186","volume":"24","author":"F Narin","year":"2004","unstructured":"Narin, F. et al. Plasma homocysteine and retinal artery occlusive disease: a case-control study. Ann Saudi Med \n                           24, 186\u2013188 (2004).","journal-title":"Ann Saudi Med"},{"key":"16065_CR30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0161-6420(00)00181-0","volume":"107","author":"P Pianka","year":"2000","unstructured":"Pianka, P. et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology \n                           107, 1588\u20131592 (2000).","journal-title":"Ophthalmology"},{"key":"16065_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1076029606296423","volume":"13","author":"G Sottilotta","year":"2007","unstructured":"Sottilotta, G. et al. Role of hyperhomocystinemia in retinal vascular occlusive disease. Clin Appl Thromb Hemost \n                           13, 104\u2013107 (2007).","journal-title":"Clin Appl Thromb Hemost"},{"key":"16065_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0002-9394(02)01471-X","volume":"134","author":"M Weger","year":"2002","unstructured":"Weger, M. et al. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol \n                           134, 57\u201361 (2002).","journal-title":"Am J Ophthalmol"},{"key":"16065_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MBC.0b013e32809cc922","volume":"18","author":"R Marcucci","year":"2007","unstructured":"Marcucci, R. et al. Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis \n                           18, 321\u2013326 (2007).","journal-title":"Blood Coagul Fibrinolysis"},{"key":"16065_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/OPTH.S80714","volume":"9","author":"S Schockman","year":"2015","unstructured":"Schockman, S. et al. Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol \n                           9, 591\u2013600 (2015).","journal-title":"Clin Ophthalmol"},{"key":"16065_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ophtha.2016.10.025","volume":"124","author":"T Calway","year":"2017","unstructured":"Calway, T. et al. Perioperative Retinal Artery Occlusion: Risk factors in cardiac surgery from the United States national inpatient sample 1998\u20132013. Ophthalmology \n                           124, 189\u2013196 (2017).","journal-title":"Ophthalmology"},{"key":"16065_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/ejh.12554","volume":"96","author":"J Schwarz","year":"2016","unstructured":"Schwarz, J. et al. Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide. Eur J Haematol \n                           96, 98\u2013106 (2016).","journal-title":"Eur J Haematol"},{"key":"16065_CR37","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.metabol.2014.05.005","volume":"63","author":"CJ Glueck","year":"2014","unstructured":"Glueck, C. J. & Wang, P. Testosterone therapy, thrombosis, thrombophilia, cardiovascular events. Metabolism \n                           63, 989\u2013994 (2014).","journal-title":"Metabolism"},{"key":"16065_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jamaophthalmol.2015.5052","volume":"134","author":"TC Hsieh","year":"2016","unstructured":"Hsieh, T. C. et al. Risk of mortality and of atherosclerotic events among patients who underwent hemodialysis and subsequently developed retinal vascular occlusion: A Taiwanese retrospective cohort study. JAMA Ophthalmol \n                           134, 196\u2013203 (2016).","journal-title":"JAMA Ophthalmol"},{"key":"16065_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-015-2335-0","volume":"403","author":"S Han","year":"2015","unstructured":"Han, S., Wu, H., Li, W. & Gao, P. Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury. Mol Cell Biochem \n                           403, 43\u201349 (2015).","journal-title":"Mol Cell Biochem"},{"key":"16065_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10620-014-3379-9","volume":"60","author":"H Ding","year":"2015","unstructured":"Ding, H. et al. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci \n                           60, 375\u2013381 (2015).","journal-title":"Dig Dis Sci"},{"key":"16065_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.taap.2012.01.026","volume":"260","author":"SJ Lee","year":"2012","unstructured":"Lee, S. J. et al. Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways. Toxicol Appl Pharmacol \n                           260, 89\u201394 (2012).","journal-title":"Toxicol Appl Pharmacol"},{"key":"16065_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2013.07.051","volume":"252","author":"PK Kamat","year":"2013","unstructured":"Kamat, P. K. et al. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience \n                           252, 302\u2013319 (2013).","journal-title":"Neuroscience"},{"key":"16065_CR43","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.ophtha.2014.04.029","volume":"121","author":"SJ Park","year":"2014","unstructured":"Park, S. J., Choi, N. K., Seo, K. H., Park, K. H. & Woo, S. J. Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011. Ophthalmology \n                           121, 1933\u20131938 (2014).","journal-title":"Ophthalmology"},{"key":"16065_CR44","first-page":"374616","volume":"2015","author":"JC Yen","year":"2015","unstructured":"Yen, J. C., Lin, H. L., Hsu, C. A., Li, Y. C. & Hsu, M. H. Atrial Fibrillation and Coronary Artery Disease as Risk Factors of Retinal Artery Occlusion: A Nationwide Population-Based Study. Biomed Res Int \n                           2015, 374616 (2015).","journal-title":"Biomed Res Int"},{"key":"16065_CR45","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA \n                           283, 2008\u20132012 (2000).","journal-title":"JAMA"},{"key":"16065_CR46","unstructured":"Wells, G. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [EB\/OL]. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16065-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16065-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:39:13Z","timestamp":1671802753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16065-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["16065"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-16065-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"assertion":[{"value":"11 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15708"}}